Crossmark

Tanshinone IIA is synergistic with the PARP inhibitor olaparib in inducing BRCAs-proficient and -deficient triple-negative breast cancer cell apoptosis

Crossref DOI link: https://doi.org/10.1007/s12032-025-02968-y

Published Online: 2025-08-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Qi

Zhou, Qian

Yang, Xiaoxuan

Yang, Jie

Liang, Lizhen

Kang, Liang

Zhang, Yamei

Deng, Yu
Funding

Funding for this research was provided by:

The Innovation Foundation of The Affiliated Hospital of Chengdu University (CDFYCX202209)

National Natural Science Foundation of China (82174202)
License Information

Text and Data Mining valid from 2025-08-09

Version of Record valid from 2025-08-09
More Information

Article History

Received: 2 May 2025

Accepted: 28 July 2025

First Online: 9 August 2025

Declarations

:

: The authors declare no competing interests.

: Not applicable.

Document is current

Any future updates will be listed below